Rotavirus strain trends during the postlicensure vaccine era: United States, 2008-2013

Journal of Infectious Diseases

Volumn 214, Issue 5, 2016, Pages 732-738

  Bowen, Michael D ^a   Mijatovic Rustempasic, Slavica ^a   Esona, Mathew D ^a   Teel, Elizabeth N ^a   Gautam, Rashi ^a   Sturgeon, Michele ^a   Azimi, Parvin H ^b   Baker, Carol J ^d,e   Bernstein, David I ^f   Boom, Julie A ^d,e   Chappell, James ^g   Donauer, Stephanie ^f   Edwards, Kathryn M ^g   Englund, Janet A ^h   Halasa, Natasha B ^g   Harrison, Christopher J ⁱ   Johnston, Samantha H ^b   Klein, Eileen J ^h   McNeal, Monica M ^f   Moffatt, Mary E ⁱ   Rench, Marcia A ^d,e   Sahni, Leila C ^d   Selvarangan, Rangaraj ⁱ   Staat, Mary A ^f   Szilagyi, Peter G ^c   Weinberg, Geoffrey A ^j   Wikswo, Mary E ^a   Parashar, Umesh D ^a   Payne, Daniel C ^a   more..

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CHILDREN S HOSPITAL OAKLAND   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d TEXAS CHILDREN S HOSPITAL   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^g VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^h SEATTLE CHILDREN S HOSPITAL   (United States)

ⁱ CHILDREN'S MERCY HOSPITALS AND CLINICS   (United States)

^j UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

more..

Author keywords

Genotype; Prevalence; Rotavirus; Surveillance; Vaccine

Indexed keywords

ROTAVIRUS VACCINE;

ACUTE GASTROENTERITIS; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SURVEILLANCE; EMERGENCY WARD; ENZYME IMMUNOASSAY; GENOTYPE; HUMAN; LICENSING; NONHUMAN; PEDIATRIC HOSPITAL; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; ROTAVIRUS A; ROTAVIRUS A GENOTYPE G12P[8]; ROTAVIRUS A GENOTYPE G24P[14]; ROTAVIRUS A GENOTYPE G2P[8]; ROTAVIRUS A GENOTYPE G3P[24]; ROTAVIRUS A GENOTYPE G3P[4]; ROTAVIRUS A GENOTYPE G3P[6]; ROTAVIRUS A GENOTYPE G3P[8]; ROTAVIRUS A GENOTYPE G4P[6]; ROTAVIRUS A GENOTYPE G8P[4]; ROTAVIRUS A GENOTYPE G9P[4]; ROTAVIRUS INFECTION; STRAIN IDENTIFICATION; TREND STUDY; UNITED STATES; VACCINATION; VIRUS DETECTION; VIRUS STRAIN; CLASSIFICATION; EPIDEMIOLOGICAL MONITORING; FEMALE; GENETICS; INFANT; ISOLATION AND PURIFICATION; MALE; PRESCHOOL CHILD; ROTAVIRUS; ROTAVIRUS INFECTIONS; VIROLOGY;

CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGICAL MONITORING; FEMALE; GENOTYPE; HUMANS; INFANT; MALE; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; UNITED STATES;

EID: 84988979950     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw233     Document Type: Article

References (45)

1. Lanata CF, Fischer-Walker CL, Olascoaga AC, Torres CX, Aryee MJ, Black RE. Global causes of diarrheal disease mortality in children <5 years of age: a systematic review. PLoS One 2013; 8:e72788.
2. Gentsch JR, Laird AR, Bielfelt B, et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis 2005; 192(pl 1):S146-59.
3. Cortese MM, Parashar UD. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009; 58:1-25.
4. Offit PA, Clark HF. RotaTeq: a pentavalent bovine-human reassortant rotavirus vaccine. Pediatr Ann 2006; 35:29-34.
5. Bernstein Di, Ward RL. Rotarix: development of a live attenuated monovalent human rotavirus vaccine. Pediatr Ann 2006; 35:38-43.
6. Tate JE, Cortese MM, Payne DC, et al. Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data. Pediatr Infect Dis J 2011; 30:S56-60.
7. Cortese MM, Tate JE, Simonsen L, Edelman L, Parashar UD. Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases. Pediatr Infect Dis J 2010; 29:489-94.
8. Curns AT, Panozzo CA, Tate JE, et al. Remarkable postvaccination spatiotemporal changes in United States rotavirus activity. Pediatr Infect Dis J 2011; 30:S54-5.
9. Payne DC, Staat MA, Edwards KM, et al. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009. Clin Infect Dis 2011; 53:245-53.
10. Payne DC, Staat MA, Edwards KM, et al. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics 2008; 122:1235-43.
11. Payne DC, Boom JA, Staat MA, et al. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin Infect Dis 2013; 57:13-20.
12. Payne DC, Currier RL, Staat MA, et al. Epidemiologic Association Between FUT2 Secretor Status and Severe Rotavirus Gastroenteritis in Children in the United States. JAMA Pediatr 2015; 169:1040-5.
13. Payne DC, Szilagyi PG, Staat MA, et al. Secular variation in United States rotavirus disease rates and serotypes: implications for assessing the rotavirus vaccination program. Pediatr Infect Dis J 2009; 28:948-53.
14. Hull JJ, Teel EN, Kerin TK, et al. United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J 2011; 30:S42-7.
15. Mijatovic-Rustempasic S, Tam KI, Kerin TK, et al. Sensitive and specific quantitative detection of rotavirus A by one-step real-time reverse transcription-PCR assay without antecedent double-stranded-RNA denaturation. J Clin Microbiol 2013; 51:3047-54.
16. Maes P, Matthijnssens J, Rahman M, Van Ranst M. RotaC: a web-based tool for the complete genome classification of group A rotaviruses. BMC Microbiol 2009; 9:238.
17. McDonald SM, McKell AO, Rippinger CM, et al. Diversity and relationships of cocirculating modern human rotaviruses revealed using large-scale comparative genomics. J Virol 2012; 86:9148-62.
18. Matthijnssens J, Bilcke J, Ciarlet M, et al. Rotavirus disease and vaccination: impact on genotype diversity. Future Microbiol 2009; 4:1303-16.
19. Matthijnssens J, Heylen E, Zeller M, Rahman M, Lemey P, Van Ranst M. Phylodynamic analyses of rotavirus genotypes G9 and G12 underscore their potential for swift global spread. Mol Biol Evol 2010; 27:2431-6.
20. Page AL, Jusot V, Mamaty AA, et al. Rotavirus surveillance in urban and rural areas of Niger, April 2010-March 2012. Emerg Infect Dis 2014; 20:573-80.
21. Cilla G, Montes M, Gomariz M, et al. Rotavirus genotypes in children in the Basque Country (North of Spain): rapid and intense emergence of the G12P[8] genotype. Epidemiol Infect 2013; 141:868-74.
22. Bucardo F, Mercado J, Reyes Y, Gonzalez F, Balmaseda A, Nordgren J. Large increase of rotavirus diarrhoea in the hospital setting associated with emergence of G12 genotype in a highly vaccinated population in Nicaragua. Clin Microbiol Infect 2015; 21:603 e1-7.
23. Esona MD, Buteau J, Lucien MA, et al. Rotavirus group A genotypes detected through diarrheal disease surveillance in Haiti, 2012. Am J Trop Med Hyg 2015; 93:54-6.
24. Kirkwood CD, Roczo-Farkas S; the Australian Rotavirus Surveillance Group. Australian Rotavirus Surveillance Program annual report, 2013. Commun Dis Intell Q Rep 2014; 38:E334-42.
25. Matthijnssens J, Nakagomi O, Kirkwood CD, Ciarlet M, Desselberger U, Van Ranst M. Group A rotavirus universal mass vaccination: how and to what extent will selective pressure influence prevalence of rotavirus genotypes? Expert Rev Vaccines 2012; 11:1347-54.
26. Kirkwood CD, Boniface K, Bishop RF, Barnes GL. Australian Rotavirus Surveillance Program: annual report, 2009/2010. Commun Dis Intell Q Rep 2010; 34:427-34.
27. Kirkwood CD, Roczo S, Boniface K, Bishop RF, Barnes GL. Australian Rotavirus Surveillance Program annual report, 2010/11. Commun Dis Intell Q Rep 2011; 35:281-7.
28. Kirkwood CD, Roczo-Farkas S, Bishop RF, Barnes GL; the Australian Rotavirus Surveillance Group. Australian Rotavirus Surveillance Program annual report, 2012. Commun Dis Intell Q Rep 2014; 38:E29-35.
29. Hill HA, Elam-Evans LD, Yankey D, Singleton JA, Kolasa M. National, state, and selected local area vaccination coverage among children aged 19-35 months-United States, 2014. MMWR Morb Mortal Wkly Rep 2015; 64:889-96.
30. Anonymous. National, state, and local area vaccination coverage among children aged 19-35 months-United States, 2009. MMWR Morb Mortal Wkly Rep 2010; 59:1171-7.
31. Khawaja S, Cardellino A, Mast TC. Hospital-based surveillance and analysis of genotype variation in Nicaragua after the introduction of the pentavalent rotavirus vaccine. Pediatr Infect Dis J 2014; 33:e25-8.
32. Payne DC, Edwards KM, Bowen MD, et al. Sibling transmission of vaccine-derived rotavirus (RotaTeq) associated with rotavirus gastroenteritis. Pediatrics 2010; 125: e438-41.
33. Donato CM, Ch'ng LS, Boniface KF, et al. Identification of strains of RotaTeq rotavirus vaccine in infants with gastroenteritis following routine vaccination. J Infect Dis 2012; 206:377-83.
34. Hemming M, Vesikari T. Detection of rotateq vaccine-derived, double-reassortant rotavirus in a 7-year-old child with acute gastroenteritis. Pediatr Infect Dis J 2014; 33:655-6.
35. Markkula J, Hemming M, Vesikari T. Detection of vaccine-derived rotavirus strains in nonimmunocompromised children up to 3-6 months after RotaTeq vaccination. Pediatr Infect Dis J 2015; 34:296-8.
36. Boom JA, Sahni LC, Payne DC, et al. Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: a case series. J Infect Dis 2012; 206:1275-9.
37. Gautam R, Esona MD, Mijatovic-Rustempasic S, Ian Tam K, Gentsch JR, Bowen MD. Real-time RT-PCR assays to differentiate wild-type group A rotavirus strains from Rotarix and RotaTeq vaccine strains in stool samples. Hum Vaccin Immunother 2014; 10:767-77.
38. Weinberg GA, Teel EN, Mijatovic-Rustempasic S, et al. Detection of novel rotavirus strain by vaccine postlicensure surveillance. Emerg Infect Dis 2013; 19:1321-3.
39. Mijatovic-Rustempasic S, Roy S, Teel EN, et al. Full genome characterization of the first G3P[24] rotavirus strain detected in humans provides evidence of interspecies reassortment and mutational saturation in the VP7 gene. J Gen Virol 2016; 97:389-402.
40. Weinberg GA, Payne DC, Teel EN, et al. First reports of human rotavirus G8P[4] gastroenteritis in the United States. J Clin Microbiol 2012; 50:1118-21.
41. Pietsch C, Petersen L, Patzer L, Liebert UG. Molecular characteristics of German G8P[4] rotavirus strain GER1H-09 suggest that a genotyping and subclassification update is required for G8. J Clin Microbiol 2009; 47:3569-76.
42. Lewis J, Roy S, Esona MD, et al. Full genome sequence of a reassortant human G9P [4] rotavirus strain. Genome Announc 2014; 2:e01284-14.
43. Quaye O, McDonald S, Esona MD, et al. Rotavirus G9P[4] in 3 countries in Latin America, 2009-2010. Emerg Infect Dis 2013; 19:1332-3.
44. Tan M, Jiang X. Histo-blood group antigens: a common niche for norovirus and rotavirus. Expert Rev Mol Med 2014; 16:e5.
45. Kambhampati A, Payne DC, Costantini V, Lopman BA. Host genetic susceptibility to enteric viruses: a systematic review and metaanalysis. Clin Infect Dis 2016; 62:11-8.